Table 3 Treatment-related toxicity: NCI CTCAE v4.0 (N=38)
Adverse events (grade ≥3) | Number of patients (%) |
|---|---|
Febrile neutropenia | 30 (79%) |
Hepatic dysfunction | 9 (24%) |
Diarrhea | 8 (21%) |
Vomiting | 7 (18%) |
Hypokalemia | 7 (18%) |
Bacterial sepsis | 6 (16%) |
Mucositis | 4 (10.5%) |
Headache | 4 (10.5%) |
Multi-organ failure | 4 (10.5%) |
Lung infection | 3 (8%) |